Gallo, O., Locatello, L. G., Mazzoni, A., Novelli, L. & Annunziato, F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunol. 14, 305–316 (2021).

Article  CAS  Google Scholar 

Sungnak, W. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681–687 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn, J. H. et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Invest. 131, e148517 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114–119 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puhach, O., Meyer, B. & Eckerle, I. SARS-CoV-2 viral load and shedding kinetics. Nat. Rev. Microbiol. 21, 147–161 (2023).

CAS  PubMed  Google Scholar 

Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693–699 (2022).

Article  CAS  PubMed  Google Scholar 

Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700–705 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7, 1161–1179 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. 21, 162–177 (2023).

CAS  PubMed  PubMed Central  Google Scholar 

Minkoff, J. M. & tenOever, B. Innate immune evasion strategies of SARS-CoV-2. Nat. Rev. Microbiol. 21, 178–194 (2023).

CAS  PubMed  PubMed Central  Google Scholar 

Sette, A. & Crotty, S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol. Rev. 310, 27–46 (2022).

Article  CAS  PubMed  Google Scholar 

Ssemaganda, A. et al. Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat. Commun. 13, 3357 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puhach, O. et al. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses. EBioMedicine 98, 104893 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pieren, D. K. J. et al. Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection. Nat. Commun. 14, 1887 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitsi, E. et al. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination. Nat. Commun. 14, 6815 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 31, 146–157 (2023).

CAS  Google Scholar 

Meyerowitz, E. A., Scott, J., Richterman, A., Male, V. & Cevik, M. Clinical course and management of COVID-19 in the era of widespread population immunity. Nat. Rev. Microbiol. 22, 75–88 (2024).

Article  CAS  PubMed  Google Scholar 

Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463–469 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Unterman, A. et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat. Commun. 13, 440 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diray-Arce, J. et al. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients. Cell Rep. Med. 4, 101079 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Wijst, M. G. P. et al. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci. Transl. Med. 13, eabh2624 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 184, 4713–4733 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sposito, B. et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell 184, 4953–4968 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chua, R. L. et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 38, 970–979 (2020).

Article  CAS  PubMed  Google Scholar 

Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319–324 (2021).

Article  PubMed  Google Scholar 

Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321–327 (2022).

Article  CAS  PubMed  Google Scholar 

Lindeboom, R. G. H. et al. Human SARS-CoV-2 challenge uncovers local and systemic response dynamics. Nature 631, 189–198 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hewitt, R. J. & Lloyd, C. M. Regulation of immune responses by the airway epithelial cell landscape. Nat. Rev. Immunol. 21, 347–362 (2021).